• Publications
  • Influence
Twist expression promotes migration and invasion in hepatocellular carcinoma
BackgroundTwist, a transcription factor of the basic helix-loop-helix class, is reported to regulate cancer metastasis. It is known to induce epithelial-mesenchymal transition (EMT). In this study,Expand
  • 119
  • 9
Analysis of HCV genotypes from blood donors shows three new HCV type 6 subgroups exist in Myanmar.
The prevalence of hepatitis C virus (HCV) genotypes in Myanmar in comparison with the rest of Southeast Asia is not well known. Serum samples were obtained from 201 HCV antibody-positive volunteerExpand
  • 42
  • 9
Human hepatocyte carcinogenesis
Hepatocellular carcinoma is the third most frequent cause of cancer-related death worldwide; and its incidence rate is increasing. Clinical and molecular medical analyses have revealed substantialExpand
  • 72
  • 5
The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis
BackgroundThe single nucleotide polymorphism (SNP) rs738409 in patatin-like phospholipase domain-containing protein 3 (PNPLA3) is associated with hepatic fat accumulation and disease progression inExpand
  • 31
  • 4
Application of radiofrequency ablation for the treatment of intermediate‐stage hepatocellular carcinoma
Transcatheter arterial chemoembolization (TACE) is a standard therapy for the treatment of intermediate‐stage hepatocellular carcinoma (HCC). In this study, we tried to elucidate the possibility ofExpand
  • 14
  • 4
Serum Glycan Markers for Evaluation of Disease Activity and Prediction of Clinical Course in Patients with Ulcerative Colitis
Background The aims of this study were to determine the change of whole-serum N-glycan profile in ulcerative colitis (UC) patients and to investigate its clinical utility. Methods We collected serumExpand
  • 42
  • 3
Functional promoter upstream p53 regulatory sequence of IGFBP3 that is silenced by tumor specific methylation
BackgroundInsulin-like growth factor binding protein (IGFBP)-3 functions as a carrier of insulin-like growth factors (IGFs) in circulation and a mediator of the growth suppression signal in cells.Expand
  • 42
  • 3
Hepatitis B virus core promoter mutations G1613A and C1653T are significantly associated with hepatocellular carcinoma in genotype C HBV-infected patients
BackgroundHepatitis B virus (HBV) is a major cause of hepatocarcinogenesis.To identify mutations relevant to hepatocellular carcinoma (HCC) development, we compared the full genome sequences of HBVExpand
  • 20
  • 3
L-Carnitine Prevents Progression of Non-Alcoholic Steatohepatitis in a Mouse Model with Upregulation of Mitochondrial Pathway
Non-alcoholic steatohepatitis (NASH) is a severe form of non-alcoholic fatty liver disease characterized by lobular inflammation, hepatocellular ballooning, and fibrosis with an inherent risk forExpand
  • 46
  • 2
Effect of pegylated interferon therapy on intrahepatic recurrence after curative treatment of hepatitis C virus-related hepatocellular carcinoma
BackgroundWe wished to determine whether pegylated interferon (PEG-IFN) therapy after curative treatment of hepatocellular carcinoma (HCC) prevents a recurrence of HCC.MethodsThirty-seven HCCExpand
  • 28
  • 2